The global immunoglobulins industry was valued at US$ 16.3 billion in 2022. Fueled by the rising prevalence of immunodeficiency diseases, a growing aging population, and the expansion of indications for use, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.2% from 2023 to 2031. This steady growth trajectory is projected to propel the industry to a value of U... https://www.transparencymarketresearch.com/immunoglobulins-market.html